bioRxivNeurosciencePreprint
Synaptic vesicle endocytosis deficits underlie GBA-linked cognitive dysfunction in Parkinson's disease and Dementia with Lewy bodies
D. J. VidyadharaiD, David C. BäckströmiD, Risha Chakraborty, Jiapeng RuaniD, Jae Min ParkiD, Pramod Kumar MistryiD, Sreeganga S. ChandraiD
Abstract
GBA is the major risk gene for Parkinsons disease (PD) and Dementia with Lewy Bodies (DLB), two common -synucleinopathies with cognitive deficits. We investigated the role of mutant GBA in cognitive decline by utilizing Gba (L444P) mutant, SNCA transgenic (tg), and Gba-SNCA double mutant mice. Notably, Gba mutant mice showed early cognitive deficits but lacked PD-like motor deficits or -synuclein pathology. Conversely, SNCA tg mice displayed age-related motor deficits, without cognitive abnormalities. Gba-SNCA mice exhibited both cognitive decline and exacerbated motor deficits, accompanied by greater cortical phospho--synuclein pathology, especially in layer 5 neurons. Single-nucleus RNA sequencing of the cortex uncovered synaptic vesicle (SV) endocytosis defects in excitatory neurons of Gba mutant and Gba-SNCA mice, via robust downregulation of genes regulating SV cycle and synapse assembly. Immunohistochemistry and electron microscopy validated these findings. Our results indicate that Gba mutations, while exacerbating pre-existing -synuclein aggregation and PD-like motor deficits, contribute to cognitive deficits through -synuclein-independent mechanisms, involving dysfunction in SV endocytosis.
- organism: mouse
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neuronopathic GBA1 L444P mutation accelerates glucosylsphingosine levels and formation of hippocampal alpha-synuclein inclusions
Casey L. Mahoney-Crane, Megha Viswanathan, … Laura A. Volpicelli‐Daley·Journal of NeurosciencePeer-reviewed·Dec 7, 2022
- AAV delivery of GBA1 suppresses alpha-synuclein accumulation in Parkinson's disease models and restores motor dysfunction in a Gaucher's disease model
Takuro Okai, Sho Sato, … Gabriele Proetzel·bioRxiv·Jun 25, 2024
- GBA1 deficiency differentially affects endolysosomal trafficking in neurons versus astrocytes
Anna J. Park, Sarah Fish, … Marie Y. Davis·bioRxiv·Jan 13, 2026
- GBA1 mutations alter neuronal firing and structure, regulating VGLUT2 and CRYAB in dopamine neurons
Eva Rodríguez‐Traver, Luz M. Suárez, … Carlos Vicario‐Abejón·bioRxiv·Aug 5, 2024
- A human GBA-L444P transgene drives early and persistent dopamine neurotransmission deficits and alpha-synuclein pathology in a mouse model of early Parkinson's disease
Natalie Connor‐Robson, Tara Diviney, … Richard Wade‐Martins·bioRxiv·May 27, 2026
- Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation
C. Galvagnion, S. Cerri, … D. A. Di Monte·bioRxiv·Nov 9, 2020